LENSAR Inc.

Last updated September 27, 2026

Organization details

Legal name
LENSAR Inc.
Ownership
Public
Status
Active
Headquarters country
United States
Ticker symbol
LNSR
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001320350

Board of directors

Chief executives

Nicholas T. Curtis · Chief Executive Officer
Dates unknown

Board connections

5 of this board's directors also sit on 7 other boards.

Network of LENSAR Inc.'s board connections Geron Corporation Geron Corporation Glaukos Corporation Glaukos Corporation HCW Biologics Inc. HCW Biologics Inc. Ocular Therapeutix Inc. Ocular Therapeutix Inc... RxSight Inc. RxSight Inc. STAAR Surgical Company STAAR Surgical Company Tarsus Pharmaceuticals Inc. Tarsus Pharmaceuticals... Aimee S. Weisner Aimee S. Weisner Elizabeth G. O'Farrell Elizabeth G. O'Farre... Gary M. Winer Gary M. Winer Richard L. Lindstrom M.D. Richard L. Lindstrom... William J. Link Ph.D. William J. Link Ph.D... LENSAR Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Aug 11, 2023 Gary M. Winer Director Open-market purchase +705 $3.60 $2,538
Aug 10, 2023 Gary M. Winer Director Open-market purchase +1,000 $3.66 $3,660
May 25, 2023 Todd B. Hammer Director, 10% owner Grant or award +9,288 — —
May 25, 2023 Thomas B. Ellis Director, 10% owner Grant or award +9,288 — —
May 25, 2023 John Peter Mclaughlin Director Grant or award +9,288 — —
May 25, 2023 Elizabeth G. O'Farrell Director Grant or award +9,288 — —
May 25, 2023 William J. Link Ph.D. Director Grant or award +9,288 — —
May 25, 2023 Gary M. Winer Director Grant or award +9,288 — —
May 25, 2023 Richard L. Lindstrom M.D. Director Grant or award +9,288 — —
May 25, 2023 Aimee S. Weisner Director Grant or award +9,288 — —
May 22, 2023 Aimee S. Weisner Director Open-market purchase +16,647 $2.75 $45,779
May 19, 2023 Aimee S. Weisner Director Open-market purchase +22,153 $2.59 $57,376
May 18, 2023 Aimee S. Weisner Director Open-market purchase +7,700 $2.61 $20,097
May 17, 2023 Aimee S. Weisner Director Open-market purchase +3,500 $2.29 $8,015
Jan 11, 2023 STAAB THOMAS R II Officer (Chief Financial Officer) Grant or award +6,656 — —

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.